Dr Ann Bowron
Tel: 0191 282 9685
Consultant Clinical Scientist (Paediatric & Metabolic Biochemistry) Blood Sciences
Qualifications: BSc, MSc, PhD, FRCPath
Office Location: Royal Victoria Infirmary
Ann started her career as a research assistant in the Metabolic Disease Unit at the Institute of Child Health, London, where she first developed her interest in inborn errors of metabolism. She went on to train as a Clinical Biochemist at Bristol Royal Infirmary and, after completion of the FRCPath, was appointed to a Principal Clinical Scientist post specialising in paediatric and metabolic biochemistry. Whilst in Bristol she studied for a PhD in cardiolipin metabolism and Barth syndrome. Ann moved to Newcastle upon Tyne Hospitals in November 2015 to take up a Consultant Clinical Scientist post, providing clinical and scientific leadership for the metabolic and paediatric biochemistry service.
Ann’s interests include inherited metabolic diseases, in particular disorders of homocysteine metabolism and Barth syndrome, and the provision of a biochemistry service to support the specialist requirements of paediatrics.
Ann is on the Mass Spectrometry Special Interest Group of the Association for Clinical Biochemistry and is Scientific Representative on the British Inherited Metabolic Diseases Group committee.
Angelini R, Lobasso S, Gorgoglione R, Bowron A, Steward CG, Corcelli A. Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as screening tool for Barth syndrome. Journal of Lipid Research 2015; 56: 1787-1794.
Bowron A, Honeychurch J, Williams M, Tsai-Goodman B, Clayton N, Jones L, Shortland GJ, Qureshi SA, Heales SJ, Steward CG. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype. Journal of Inherited Metabolic Disease 2015; 38: 279-286
Clarke S, Bowron A, Steward CG et al. Barth syndrome: an under-diagnosed multisystem disease. Orphanet Journal of Rare Diseases 2013; 8: 23-40
Bowron A, Frost R, Powers VEC, Thomas PH, Heales SJR, Steward CG. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis. Journal of Inherited Metabolic Disease 2013; 36: 741-6